Search Results 961-970 of 21660 for Inhibition

1. A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Requires treatment with a strong cytochrome CYP3A4 inhibitor/inducer. The use of strong CYP3A inhibitors within 1 week or strong CYP3A inducers within 3 weeks ...

2. Coughing more after quitting smoking: What's the deal? - Mayo Clinic

   Selective serotonin reuptake inhibitors (SSRIs) · Serotonin and norepinephrine reuptake inhibitors (SNRIs) · Smokeless tobacco products · Stop-smoking services ...

3. Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM - Mayo Clinic

   Participation eligibility · Pleurodesis within 14 days prior to first dose of study drug · Receiving TNF pathway inhibitors, PI3 kinase inhibitors, systemic ...

4. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) - Mayo Clinic

   ... inhibitors (e.g., tacrolimus and cyclosporine), or mycophenolate mofetil may be enrolled only after consultation with the Medical Monitor, and only if the ...

5. Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma - Mayo Clinic

   ... inhibitor or inducer during the study * Use of a strong or moderate CYP3A inhibitor or inducer =\< 7 days prior to registration. NOTE: Because of their ...

6. Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies - Mayo Clinic

   Use of proton-pump inhibitors within 4 days prior to the first dose of study drug. Other medications that increase gastric pH, ie, histamine H2 receptor ...

7. A Study of the Effect of Methylnaltrexone on Movement Through the Digestive Tract in Healthy Volunteers - Mayo Clinic

   Analgesic drugs including opiates, NSAID, and COX 2 inhibitors. Tylenol is permitted. GABAergic agents and benzodiazepines. Concomitant medications will be ...

8. Mayo Mouse Helps Fight Multiple Myeloma

   ... inhibitors and CAR T-cell therapy. These immunotherapies work by revealing ... As a result, a second trial, combining LCL161 with a checkpoint inhibitor, is also ...

9. A Study to Evaluate Betrnet Stem Cells and the Origins of Barrett's Esophagus - Mayo Clinic

   Patients who cannot tolerate proton pump inhibitors. Pre-existing esophageal strictures. Pregnant or nursing women. More information. Publications.

10. Dichlorphenamide (oral route) - Side effects & dosage - Mayo Clinic

    This medicine is a carbonic anhydrase inhibitor. This medicine is available only with your doctor's prescription. This product is available in the following ...